Twist Bioscience

IPO

We lead innovation in DNA synthesis

Public · South San Francisco, United States · Founded 2013 · $193.1M raised

Employees
1001–5000
Founded
2013
Business Model
B2B
Total Funding
$193.1M
Last Round
$27.0M Extension RoundJun 2017
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Twist Bioscience developed a proprietary semiconductor-based DNA synthesis platform that miniaturizes chemistry using silicon chips with 10,000 nanowells. The company manufactures synthetic genes, oligo pools, NGS target enrichment kits, variant libraries, and antibody discovery tools. Its products serve researchers across therapeutics, diagnostics, agriculture, data storage, and industrial biotechnology worldwide.

Summary

Twist Bioscience is a Biotech company based in South San Francisco, United States, founded in 2013. It has raised $193.1M in total across 6 rounds, most recently a $27.0M Extension Round in Jun 2017. Investors include ARCH Venture Partners, Illumina Ventures and Biomatics Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOOct 2018
$75.0M

Sign up to see all 7 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Twist Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/twist-bioscience"><img src="https://indexed.vc/api/badge/company/twist-bioscience" alt="Twist Bioscience on Indexed.vc" width="260" height="76" /></a>